January 16, 2007

The common shares of Nexia Biotechnologies Ltd. have been approved for listing on CNQ. There are approximately 24 million common shares outstanding with a public float of 15.2 million shares. Nexia's principal business is the development and manufacturing of recombinant proteins in the form of biomaterials with industrial and medical applications. The operating assets of the Corporation were acquired from Nexia Biotechnologies Inc. pursuant to a Plan of Arrangement which closed effective October 23, 2006.

Listing and disclosure documents for Nexia Biotechnologies Ltd. will be available in the CNQ Listings Disclosure Hall

Trading Date: Tuesday, January 23, 2007
Symbol: NXBL
CUSIP: 65337U 10 0

Applications are being accepted for Market Makers for "NXBL". If you have any questions or require further information please contact Radhika Joseph at (416) 572-2000 X 2435 or E-mail: radhika.joseph@cnq.ca